Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of person privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel, Molecular Pathways of Bladder Cancer Progression.
Date: July 9-11, 2000.
Time: 7:00 PM to 12:00 PM.
Agenda: To review and evaluate grant applications.
Place: The Fitzpatrick Manhattan Hotel, 687 Lexington at E. 57th Street, New York, NY 10022.
Contact Person: Christopher L. Hatch, Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8044, Bethesda, MD 20892, (301) 496-4964.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.397, Cancer Centers Support, 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Cancer Institute, HHS)Start Signature
Dated: June 8, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-14967 Filed 6-13-00; 8:45 am]
BILLING CODE 4140-01-M